~~<i id='72F3526211'><strike id='72F3526211'><tt id='72F3526211'><pre id='72F3526211'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

Wikipedia

author：leisure time 2025-09-06 02:14:17 - browse：5421

The FDA building -- First Opinion coverage from STAT — Adobe

WASHINGTON — The Food and Drug Administration’s top cancer drug regulator doesn’t always ask for permission before taking on big initiatives.

Richard Pazdur, director of the FDA Oncology Center of Excellence, hates bureaucracy. It stifles his ideas for getting treatments to cancer patients faster — of which there are many.

To cut through that bureaucracy, Pazdur has a trick: “Don’t tell anybody,” he said to laughter at a meeting of the advocacy group Friends of Cancer Research Tuesday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： MoonLake credibility takes another hit with mid

hotspot

knowledge

hotspot

focus

explore

knowledge

WinMcNamee/GettyImagesWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiot

WSS

Will General Catalyst be the first of many hospital takeovers?

Readout LOUD podcast: mifepristone case, GLP

Abortion pill case raises question: who can sue the FDA?

States should stop sabotaging methadone treatment reform

FDA's naming rule on biosimilars has undermined competition

Medicare solvency divides Republicans at the presidential debate

focus

Wikipedia

hotspot

23andMe had bad news about my health. I wish a person had delivered it

Oprah kicked off a national conversation on obesity. Let's have it

Anesthesiologist group: stop taking Ozempic before surgery

Patient advocates debate FDA's accelerated approval process

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Readout LOUD podcast: mifepristone case, GLP

The high cost of giving birth even with insurance

Don't let 'shelved assets' gather dust. Make them into new lifesaving drugs

Wildfire smoke exposes gaps in outdoor worker protections

Diversify hospital leadership teams to protect BIPOC patient health

knowledge

MoonLake credibility takes another hit with mid

Readout Newsletter: Merck, Vertex, and Viking updates

Just how powerful is the placebo effect?

Roche subsidiary Foundation Medicine opens new headquarters

Vertex Pharmaceuticals may move headquarters in Boston

Abortion pill case raises question: who can sue the FDA?

hotspot

focus

explore

knowledge